These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28834763)

  • 1. Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo.
    Li S; Li C; Jin S; Liu J; Xue X; Eltahan AS; Sun J; Tan J; Dong J; Liang XJ
    Biomaterials; 2017 Nov; 144():119-129. PubMed ID: 28834763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
    Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance.
    Ang WH; Khalaila I; Allardyce CS; Juillerat-Jeanneret L; Dyson PJ
    J Am Chem Soc; 2005 Feb; 127(5):1382-3. PubMed ID: 15686364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
    Chen H; Wang X; Gou S
    J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug.
    Lee KGZ; Babak MV; Weiss A; Dyson PJ; Nowak-Sliwinska P; Montagner D; Ang WH
    ChemMedChem; 2018 Jun; 13(12):1210-1217. PubMed ID: 29637702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
    ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Pt(iv) complexes containing a glutathione S-transferase inhibitor lead to enhancing anticancer activity and preventing metastasis of osteosarcoma cells.
    Chen H; Chen F; Wang X; Gou S
    Metallomics; 2019 Feb; 11(2):317-326. PubMed ID: 30560252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers.
    Han Y; Yin W; Li J; Zhao H; Zha Z; Ke W; Wang Y; He C; Ge Z
    J Control Release; 2018 Mar; 273():30-39. PubMed ID: 29371047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines.
    Bernig T; Ritz S; Brodt G; Volkmer I; Staege MS
    Anticancer Res; 2016 Aug; 36(8):3905-15. PubMed ID: 27466493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation.
    Parker LJ; Italiano LC; Morton CJ; Hancock NC; Ascher DB; Aitken JB; Harris HH; Campomanes P; Rothlisberger U; De Luca A; Lo Bello M; Ang WH; Dyson PJ; Parker MW
    Chemistry; 2011 Jul; 17(28):7806-16. PubMed ID: 21681839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short divalent ethacrynic amides as pro-inhibitors of glutathione
    Xu B; Tong T; Wang X; Liu F; Zhang X; Hu X; Li X; Yang X; Liao F
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):728-742. PubMed ID: 35176963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
    Rhodes T; Twentyman PR
    Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
    Li L; Huang X; Huang R; Gou S; Wang Z; Wang H
    Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glutathione-S-transferase in anti-cancer drug resistance.
    Townsend DM; Tew KD
    Oncogene; 2003 Oct; 22(47):7369-75. PubMed ID: 14576844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An H₂O₂-responsive nanocarrier for dual-release of platinum anticancer drugs and O₂: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cells.
    Chen H; He W; Guo Z
    Chem Commun (Camb); 2014 Sep; 50(68):9714-7. PubMed ID: 25017175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy.
    Zhou D; Cong Y; Qi Y; He S; Xiong H; Wu Y; Xie Z; Chen X; Jing X; Huang Y
    Biomater Sci; 2015 Jan; 3(1):182-91. PubMed ID: 26214201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
    Byun SS; Kim SW; Choi H; Lee C; Lee E
    BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
    Singh S
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):1-15. PubMed ID: 25143300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic effects of ethacrynic acid.
    Somberg JC; Molnar J
    Am J Ther; 2009; 16(1):102-4. PubMed ID: 19142157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells.
    Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA
    In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.